Search results
Ozempic maker slams Biden after the president accused the drug company of ‘ripping off’ US consumers
The Independent via Yahoo News Singapore· 4 hours agoOzempic’s price “has decreased approximately 40 percent since launch and over 80 percent of...
NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Zacks via Yahoo Singapore Finance· 9 hours agoA new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's...
Joe Biden and Bernie Sanders Demand Drug Companies Cut Price of Ozempic and Other New Weight Loss...
Futurism via Yahoo News Singapore· 24 hours agoIn a dual-bylined editorial, President Joe Biden and Sen. Bernie Sanders called on the makers of the...
A New Alzheimer’s Drug May Be the Most Effective One Yet
Time via Yahoo News Singapore· 1 day ago“The overwhelming lesson from our dataset is that the earlier you identify a patient and give them...
Watchdog Calls on Eli Lilly to Denounce Supreme Court Puppetmaster’s Firm
Rolling Stone via Yahoo News Singapore· 1 day agoOn Wednesday, following the conclusion of another radically right-wing Supreme Court term, the...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Singapore Finance· 1 day agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
Factbox-Stocks to watch as Biden and Trump vie for presidency
Reuters via Yahoo Singapore Finance· 1 day agoAND INSURERS UBS sees a lower risk of drug price cuts and an inclination towards Medicare Advantage...
5 things to know for July 3: Presidential race, Hurricane Beryl, India crowd crush, Alzheimer’s...
CNN via Yahoo News Singapore· 1 day agoAlzheimer’s treatment The FDA on Tuesday approved a new drug to slow the progression of early symptomatic Alzheimer’s disease. Donanemab, made by the pharmaceutical giant Eli
Fighting words: Lilly and Novo swat back at the Biden/Sanders call for lower GLP-1 prices
Yahoo Finance· 2 days agoNovo CEO Lars Jørgensen has agreed to testify before Sanders' committee in late September. But the...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
CNN via Yahoo News Singapore· 2 days agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.